CA Ramesh Kr Kedia

IRIS Multi Speciality Hospital - Director

[🇮🇳 Focused Investing @ParveenBhansali]

#SyrmaSGS
Key Growth Drivers for FY27-28 🚀

- Management confidence is rising: The tone has shifted from simply "achieving" guidance to "exceeding" it. Management believes FY27 growth can surpass the 35%+ revenue guidance, provided geopolitical disruptions remain under control.

- Strong execution visibility: Around ₹5,400 crore of the ₹6,770 crore order book is scheduled for execution over the next 12 months, providing excellent revenue visibility.

- Exports remain a major growth engine: Management expects 30-40% export growth in FY27, with exports carrying a superior margin profile and increasing integration into global supply chains.

- ODM scaling up: The high margin Own Design Manufacturing (ODM) business continues to expand, improving both profitability and customer stickiness.

- Healthcare momentum: A ₹500 crore healthcare order book and management's expectation of 50% growth in the MedTech business make healthcare one of the fastest growing verticals.

- Defence recovery: Management expects the defence business to strengthen progressively over the coming quarters as new technologies and product offerings are added.

- Automotive electrification: Rising demand for EV electronics and charging infrastructure continues to drive strong growth in the automotive segment.

- New technology opportunities: Development of server motherboard manufacturing with select customers opens up a new avenue to participate in AI and data centre infrastructure.

- RFID solutions gaining traction: The RFID business continues to scale, supported by increasing adoption across industries.

- Water purification electronics: This vertical is witnessing healthy demand and is emerging as another growth contributor.

- Telecom recovery: The telecom business is showing signs of revival, adding another layer to the company's diversified growth profile.

- Future revenue pipeline: The company onboarded 18 new customers during Q1. While these programs will ramp up over the next 12-30 months, management believes they represent a ₹1,000+ crore long term revenue opportunity.

Why FY27 Could Be a Re-rating Year
- Strong execution backed by a large executable order book.

- High margin exports and ODM becoming a larger share of revenue.

- Multiple verticals - Healthcare, EV, Defence and Telecom growing simultaneously.

- Management publicly indicating confidence in exceeding, not just meeting, FY27 guidance.

- A healthy pipeline of new customers creating visibility well beyond FY27.

[CA Ramesh Kr Kedia @kedia_ramesh]

@ParveenBhansali Excellent coverage

[CA Ramesh Kr Kedia @kedia_ramesh]

@MarieNoell95359 Ok

[CA Ramesh Kr Kedia @kedia_ramesh]

@Priyaa_Purohit No, never in this life

[CA Ramesh Kr Kedia @kedia_ramesh]

@mrgroowth What are these days?

[CA Ramesh Kr Kedia @kedia_ramesh]

@GeniusGTX How to get it

[CA Ramesh Kr Kedia @kedia_ramesh]

@sathyashrii Yes

[Megh Updates 🚨™ @MeghUpdates]

Do you support Justice GR Swaminathan...?

[CA Ramesh Kr Kedia @kedia_ramesh]

@MeghUpdates Yes, very much

[CA Ramesh Kr Kedia @kedia_ramesh]

@GitaShlokas_ Yes

[CA Ramesh Kr Kedia @kedia_ramesh]

@MentalUnleash Health

[CA Ramesh Kr Kedia @kedia_ramesh]

@GrowSmarter_x 42

[CA Ramesh Kr Kedia @kedia_ramesh]

@Sheetal2242 You are also terrorist

[CA Ramesh Kr Kedia @kedia_ramesh]

@Priyaa_Purohit You are terrorist

[CA Ramesh Kr Kedia @kedia_ramesh]

@TheIncNews सक्षम है

[CA Ramesh Kr Kedia @kedia_ramesh]

@SocialistLeadr आप सबसे बड़े चोर और आतंकबादी हो।

[CA Ramesh Kr Kedia @kedia_ramesh]

@TejashwiYdvRJD एकदम निस्पक्ष और सही हुआ है।

[CA Ramesh Kr Kedia @kedia_ramesh]

@TheIncNews 01 sahi

[CA Ramesh Kr Kedia @kedia_ramesh]

@TheIncNews @RahulGandhi @INCIndia No